192 related articles for article (PubMed ID: 9001894)
1. Impact of renin-angiotensin system blockade on structure and function of glomerular membrane components in animal models of kidney disease.
Remuzzi A; Mohamed EI
Exp Nephrol; 1996; 4 Suppl 1():27-33. PubMed ID: 9001894
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.
Brewster UC; Perazella MA
Am J Med; 2004 Feb; 116(4):263-72. PubMed ID: 14969655
[TBL] [Abstract][Full Text] [Related]
3. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
Ibrahim HN; Rosenberg ME; Hostetter TH
Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
[TBL] [Abstract][Full Text] [Related]
4. Kidney angiotensin receptors and their role in renal pathophysiology.
Sandberg K; Ji H
Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
[TBL] [Abstract][Full Text] [Related]
5. From converting enzyme inhibition to angiotensin II receptor blockade: new insight on angiotensin II receptor subtypes in the kidney.
Wolf G; Neilson EG
Exp Nephrol; 1996; 4 Suppl 1():8-19. PubMed ID: 9001892
[TBL] [Abstract][Full Text] [Related]
6. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
Mifsud SA; Allen TJ; Bertram JF; Hulthen UL; Kelly DJ; Cooper ME; Wilkinson-Berka JL; Gilbert RE
Diabetologia; 2001 Jul; 44(7):878-82. PubMed ID: 11508273
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
Sandmann S; Unger T
Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
[TBL] [Abstract][Full Text] [Related]
8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular hypertrophy induced by angiotensin II.
Wolf G; Ziyadeh FN
Semin Nephrol; 1997 Sep; 17(5):448-54. PubMed ID: 9316213
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease.
Raij L
Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551
[TBL] [Abstract][Full Text] [Related]
12. Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury?
Ryan MJ; Tuttle KR
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):443-9. PubMed ID: 18695383
[TBL] [Abstract][Full Text] [Related]
13. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
Weinberg MS; Weinberg AJ; Zappe DH
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
[No Abstract] [Full Text] [Related]
14. Angiotensin receptors and development: the kidney.
Alcorn D; McCausland JE; Maric C
Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S88-92. PubMed ID: 21143279
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
[TBL] [Abstract][Full Text] [Related]
18. [ACE inhibitor effects on structure and function of the glomerular basement membrane].
Hasslacher C; Bostedt-Kiesel A; Kempe HP
Klin Wochenschr; 1992; 69 Suppl 29():39-44. PubMed ID: 1614191
[TBL] [Abstract][Full Text] [Related]
19. Glomerular scarring: can we delay or even reverse glomerulosclerosis by RAAS inhibition?
Moeller MJ
Nephrol Dial Transplant; 2010 Jul; 25(7):2101-3. PubMed ID: 20388634
[No Abstract] [Full Text] [Related]
20. Comparison of renin-angiotensin to calcium channel blockade in renal disease.
Tikkanen I; Johnston CI
Kidney Int Suppl; 1997 Dec; 63():S19-22. PubMed ID: 9407414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
